Eye Cancer
Oncology·MeSH: Eye Neoplasms
Prevalence
2.0 / 100K
Incidence
0.3 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| AU-011 | Aura Biosciences, Inc. (AURA) |
Frequently asked questions
How many drugs are in development for Eye Cancer?
BioSniper tracks 1 drug in development for Eye Cancer across 1 company.
How many clinical trials target Eye Cancer?
There are 1 clinical trial targeting Eye Cancer tracked by BioSniper.
What is the prevalence of Eye Cancer?
The estimated prevalence of Eye Cancer is approximately 2.0 per 100,000 population.
Deep-dive into Eye Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis